Critical Care Profile (13+4)
A veterinary rapid-response panel for unstable and emergency patients, combining 13 measured analytes with 4 calculated indicators to support electrolyte assessment, acid-base interpretation, renal monitoring, glucose control, calcium-phosphorus balance, and tissue perfusion follow-up.
High-value clinical uses
Useful for emergency triage, shock assessment, fluid therapy monitoring, acute kidney injury follow-up, endocrine and electrolyte emergencies, peri-anesthetic instability, and ICU trend monitoring.
Core coverage
Renal markers, glucose, major electrolytes, calcium-phosphorus-magnesium balance, total carbon dioxide, pH, lactate, and four calculated pattern indicators.
Panel advantage
Focuses on the measurements clinicians need most when deciding whether a patient is dehydrated, acidotic, hypoperfused, hyperkalemic, azotemic, or responding to treatment.
What this panel is for
The Critical Care Profile (13+4) is intended for patients that need rapid biochemical decision support rather than broad wellness screening. It is especially valuable in emergency and intensive-care settings where electrolyte changes, acid-base disturbance, acute renal compromise, dysglycemia, and tissue hypoperfusion can change quickly and materially affect treatment. In practical use, this panel helps support decisions about fluid selection, urgency of potassium correction, interpretation of metabolic acidosis or alkalosis, severity of azotemia, calcium-phosphorus risk patterns, and whether hyperlactatemia is persisting or improving over time.
Measured test items (13)
Calculation items (4)
*Calculated indicators improve triage interpretation, but none should be treated as a diagnosis on its own. They are most useful when read beside the source analytes and the patient’s clinical state.
Sample, workflow, and handling
Specimen
Use the validated specimen type and anticoagulant specified by the analyzer IFU and local laboratory procedure for the exact critical care panel configuration.
Emergency-use emphasis
Because pH, tCO2, lactate, and potassium can change quickly after collection, preanalytical handling matters more here than in routine wellness chemistry.
Prompt analysis
Analyze as soon as possible after collection and minimize unnecessary delay, air exposure, and warm storage when acid-base or lactate interpretation is clinically important.
Interpretive caution
Hemolysis can falsely increase potassium; delayed processing can lower glucose and alter lactate and tCO2; pH interpretation is especially vulnerable to poor handling.
- Potassium: hemolysis, platelet release, or contamination can falsely increase results and lead to overestimation of emergency severity.
- Glucose: storage on cells can cause falsely low values if separation or analysis is delayed.
- Lactate and tCO2: delayed analysis and storage on cells can create ex vivo changes that do not reflect the patient.
- pH: this is highly preanalytical-sensitive; exposure to air and delayed testing can materially distort interpretation.
Clinical interpretation by analyte group
Renal and azotemia assessment
CRE, BUN, and BUN/CRE provide rapid support for assessing reduced filtration, prerenal disproportion, and treatment response in dehydrated or oliguric patients. Creatinine is the stronger filtration marker, while urea is more influenced by hydration, GI bleeding, catabolism, and hepatic urea production.
Electrolyte emergencies
Na+, K+, Cl-, Mg, and the Na+/K+ ratio are central for triage of dehydration, free-water imbalance, urinary obstruction, adrenal disease suspicion, severe GI loss, renal compromise, and arrhythmia risk. Potassium deserves immediate attention when markedly increased or decreased.
Acid-base status
tCO2, pH, Cl-, and AG help determine whether a patient is acidotic or alkalotic and whether the metabolic pattern is more consistent with chloride-related disturbance or accumulation of unmeasured acids. Total CO2 gives a useful metabolic clue, but it does not replace a full blood gas assessment.
Perfusion and shock support
LAC is a high-value marker for tissue hypoperfusion and critical illness monitoring. Hyperlactatemia can support concern for shock or severe systemic disease, but lactate may also increase without a true metabolic acidosis and should be trended, not over-read in isolation.
Glucose and metabolic control
GLU helps detect diabetes-related emergencies, stress hyperglycemia, sepsis-associated hypoglycemia, insulin-related hypoglycemia, and other rapidly changing metabolic states.
Mineral and tissue-risk assessment
Ca, P, Mg, and Ca×P add value in renal failure, obstruction, endocrine disease, muscle and neuromuscular instability, and mineralization-risk states. The calcium-phosphorus product becomes especially relevant when both analytes are increased.
Hepatic context
ALT is included as a contextual injury marker. In critical care cases, mild to moderate ALT increases can accompany shock, hypoxia, drug effects, or primary hepatocellular injury, but ALT alone does not establish hepatic functional failure.
Quick high / low interpretation guide
| Analyte | Main intent of use | When high may suggest | When low may suggest / key notes |
|---|---|---|---|
| ALT | Hepatocellular injury context | Hepatocellular leakage or secondary hypoxic injury | Low values usually not clinically useful |
| CRE | Filtration marker | Reduced GFR, renal or postrenal causes | May be lower in low-muscle-mass patients |
| BUN | Azotemia and protein metabolism support | Prerenal azotemia, renal disease, GI bleeding, catabolism | Low protein intake, hepatic dysfunction, dilution |
| GLU | Metabolic and emergency screening | Stress hyperglycemia, diabetes mellitus, endocrine or iatrogenic causes | Sepsis, insulin excess, juvenile causes, severe hepatic dysfunction, delayed analysis artifact |
| K+ | Arrhythmia and neuromuscular risk | Urinary obstruction, renal failure, hypoadrenocorticism, acidosis, hemolysis artifact | GI loss, diuresis, insulin effect, alkalosis, poor intake; both extremes can be dangerous |
| Na+ | Water-balance assessment | Water deficit or hypertonic gain | Dilution, sodium loss, adrenal disease, severe GI or renal loss patterns |
| Cl- | Acid-base and fluid pattern support | Relative hyperchloremia supports normal-anion-gap metabolic acidosis or chloride-rich fluid effect | Relative hypochloremia supports vomiting/gastric loss or metabolic alkalosis patterns |
| Ca | Mineral and excitability balance | Hypercalcemia, renal or endocrine disease, neoplasia, vitamin D-related states | Hypoalbuminemia effect or true hypocalcemia; confirm with ionized calcium when needed |
| P | Renal and mineral balance | Reduced excretion, cell breakdown, growth, vitamin D disorders | Poor intake, losses, endocrine causes |
| Mg | Neuromuscular and electrolyte support | Reduced excretion or magnesium administration | GI or renal loss; can contribute to weakness and refractory electrolyte instability |
| tCO2 | Metabolic acid-base clue | Metabolic alkalosis or compensation patterns | Metabolic acidosis or ex vivo artifact with delayed handling |
| pH | Overall acid-base status | Alkalemia | Acidemia; interpretation must consider handling and respiratory context |
| LAC | Perfusion and critical illness marker | Hypoperfusion, shock, severe systemic disease, seizures, strenuous exertion; trend over time matters | Low values are usually not clinically significant |
| BUN/CRE* | Prerenal vs disproportion clue | Disproportionately high BUN supports dehydration, GI bleeding, or catabolism | Lower ratio may fit lower urea production or relatively higher creatinine |
| Na+/K+* | Electrolyte pattern index | Higher ratio may accompany sodium excess or potassium loss | Low ratio raises suspicion for adrenal-pattern disease or marked hyperkalemia, but it is not diagnostic by itself |
| Ca×P* | Mineralization risk screen | Higher product increases concern for soft tissue mineralization risk | Context-dependent; interpret with renal status and total calcium caveats |
| AG* | Unmeasured-anion screen | High anion gap supports accumulation of lactate, ketones, uremic acids, or toxins | Normal gap does not exclude serious illness; read beside chloride and tCO2 |
Pattern-based diagnostic scenarios
1) Hypoperfusion / shock pattern
Lactate increased, pH decreased, tCO2 decreased, and the anion gap may rise. This pattern supports tissue hypoxia or poor perfusion and is especially valuable when trended during resuscitation.
2) Hyperkalemic emergency
Potassium increased, often with azotemia and a reduced Na+/K+ ratio. Consider urinary obstruction, acute kidney injury, severe adrenal-pattern disease, or major acid-base disturbance, while ruling out hemolysis artifact immediately.
3) Prerenal azotemia / dehydration
BUN and creatinine increase, with BUN sometimes rising more than creatinine. Sodium and chloride may also reflect water deficit, depending on the clinical picture and fluid losses.
4) Metabolic acidosis with unmeasured acids
Low tCO2 with a high anion gap, often with increased lactate. This supports lactic acidosis, ketoacidosis, uremic acids, or selected toxic causes rather than a pure chloride-driven disturbance.
5) Hyperchloremic / normal-gap acidosis
tCO2 decreased with disproportionate chloride increase and no marked anion-gap rise. This fits chloride-rich losses or gains, including some GI or fluid-therapy related metabolic acidoses.
6) Vomiting / chloride-depletion alkalosis
Chloride decreased relative to sodium and tCO2 increased, often with alkalemia. This pattern supports gastric acid loss or chloride-responsive metabolic alkalosis.
7) Diabetic crisis support pattern
Marked hyperglycemia with low tCO2 and increased anion gap raises concern for diabetic ketoacidosis or other severe dysglycemic emergencies. Potassium status may be misleading if total-body potassium is depleted despite a normal or high measured value.
8) Acute kidney injury / postrenal pattern
Creatinine and BUN rise together, phosphorus may increase, potassium may increase, and acid-base abnormalities often develop as excretion worsens. Calcium-phosphorus product becomes more clinically relevant as both values rise.
9) Low Na+/K+ ratio pattern
A reduced Na+/K+ ratio can support suspicion for hypoadrenocorticism or severe hyperkalemic states, but it should never be used as a stand-alone diagnosis. Confirmatory endocrine testing and full clinical context are still required.
10) Mineralization-risk pattern
Both calcium and phosphorus increased, raising the Ca×P product. This heightens concern for soft-tissue mineralization risk, especially in severe renal disease or vitamin D-related toxicosis.
11) Treatment-response trend
Declining lactate, improving pH and tCO2, falling potassium toward normal, and stabilizing azotemia are often more informative than a single isolated pre-treatment snapshot.
12) Secondary hepatic leakage in critical illness
Mild to moderate ALT increase in an unstable patient may reflect secondary hypoxic or inflammatory liver injury rather than primary hepatic disease. Interpret beside perfusion markers and the rest of the emergency picture.
Why these calculated items matter
BUN/CRE
Helpful when urea is changing out of proportion to creatinine, especially in dehydration, GI bleeding, catabolic states, or when hepatic urea production is altered.
Na+/K+
Useful as a quick screening ratio in electrolyte emergencies. A low ratio can support an adrenal-pattern suspicion or severe hyperkalemic state, but it is a clue rather than proof.
Ca×P
Gives a simple tissue-mineralization risk indicator when calcium and phosphorus are both increased, especially in severe renal dysfunction or toxicosis contexts.
AG
Highlights whether unmeasured anions are contributing to metabolic acidosis. It becomes especially useful when read together with lactate, chloride, pH, and tCO2.
Reference interval and implementation note
References
Primary product / IFU reference
- Tianjin MNCHIP Technologies Co., Ltd. Celercare V / Pointcare V chemistry analyzer IFU. Use the validated panel-specific insert for specimen type, analyzer compatibility, sample handling, and reference interval verification for the exact Critical Care Profile configuration.